-
1. Freedom Space 3.0: ML-Assisted Selection of Synthetically Accessible Small Molecules
-
2. CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
-
3. Identification of novel Mycobacterium tuberculosis leucyl-tRNA synthetase inhibitors with antibacterial activity
-
4. In vitro evaluation of the immunogenic potential of gramicidin S and its photocontrolled analogues
-
5. MOSAEC-DB: a comprehensive database of experimental metal–organic frameworks with verified chemical accuracy suitable for molecular simulations
-
6. Incorporation of Ligand Charge and Metal Oxidation State Considerations into the Computational Solvent Removal and Activation of Experimental Crystal Structures Preceding Molecular Simulation
-
7. The freedom space – a new set of commercially available molecules for hit discovery
-
8. Development of a Potent and Selective G2A (GPR132) Agonist
-
9. Structure-based discovery of CFTR potentiators and inhibitors
-
10. AlphaFold2 structures guide prospective ligand discovery
-
11. Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography
-
12. Docking for EP4R antagonists active against inflammatory pain
-
13. The challenge of balancing model sensitivity and robustness in predicting yields: a benchmarking study of amide coupling reactions
-
14. Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors
-
15. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes
-
16. AI-Powered Virtual Screening of Large Compound Libraries Leads to the Discovery of Novel Inhibitors of Sirtuin-1
-
17. Computer-Aided Design Of Muscarinic Acetylcholine Receptor M3 Inhibitors: Promising Compounds Among Trifluoromethyl Containing Hexahydropyrimidinones/Thiones
-
18. Discovery, Synthesis, and In Vitro Characterization of 2,3 Derivatives of 4,5,6,7-Tetrahydro-Benzothiophene as Potent Modulators of Retinoic Acid Receptor-Related Orphan Receptor γt
-
19. ZINC-22─A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery
-
20. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
-
21. Challenges for chemistry in Ukraine after the war: Ukrainian science requires rebuilding and support
-
22. C−C Coupling through Nitrogen Deletion: Application to Library Synthesis
-
23. Advancing molecular graphs with descriptors for the prediction of chemical reaction yields
-
24. Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds
-
25. Magnet for the Needle in Haystack: “Crystal Structure First” Fragment Hits Unlock Active Chemical Matter Using Targeted Exploration of Vast Chemical Spaces
-
26. Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor
-
27. The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd
-
28. In Vitro and In Silico Evaluation of Cholinesterase Inhibition by Alkaloids Obtained from Branches of Abuta panurensis Eichler
-
29. Creation of targeted compound libraries based on 3D shape recognition
-
30. Virtual Screening in Search for a Chemical Probe for Angiotensin-Converting Enzyme 2 (ACE2)
-
31. A Close-up Look at the Chemical Space of Commercially Available Building Blocks for Medicinal Chemistry
-
32. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
-
33. Structures of the σ2 receptor enable docking for bioactive ligand discovery
-
34. SynthI: A New Open-Source Tool for Synthon-Based Library Design
-
35. Scalable Approach to Fluorinated Heterocycles with Sulfur Tetrafluoride (SF4)
-
36. One-pot parallel synthesis of 1,3,5-trisubstituted 1,2,4-triazoles
-
37. Synthesis of α-substituted 2-(1H-1,2,4-triazol-3-yl)acetates and 5-amino-2,4-dihydro-3H-pyrazol-3-ones via the Pinner strategy
-
38. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
-
39. Generating Multibillion Chemical Space of Readily Accessible Screening Compounds
-
40. SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules
-
41. ZINC20—A Free Ultralarge-Scale Chemical Database for Ligand Discovery
-
43. Synthesis, biological evaluation, and modeling studies of 1,3-disubstituted cyclobutane-containing analogs of combretastatin A4
-
44. Multigram Synthesis of Advanced 6,6-Difluorospiro[3.3]heptane-Derived Building Blocks
-
45. Synthesis of Spirocyclic β‐ and γ‐Sultams by One‐Pot Reductive Cyclization of Cyanoalkylsulfonyl Fluorides
-
46. An open-source drug discovery platform enables ultra-large virtual screens
-
47. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
-
48. Sulfonimidamides and Imidosulfuric Diamides: Compounds from an Underexplored Part of Biologically Relevant Chemical Space
-
49. (Het)aryl Difluoromethyl-Substituted β-Alkoxyenones: Synthesis and Heterocyclizations
-
50. Regioselective Synthesis of Functionalized 3- or 5-Fluoroalkyl Isoxazoles and Pyrazoles from Fluoroalkyl Ynones and Binucleophiles
-
51. Synthesis of 5-(Fluoroalkyl)isoxazole Building Blocks by Regioselective Reactions of Functionalized Halogenoximes
-
52. SAR by Space: Enriching Hit Sets from the Chemical Space
-
53. One-Pot Parallel Synthesis of 5-(Dialkylamino)tetrazoles
-
54. Pros and cons of virtual screening based on public ‘Big Data’: In silico mining for new bromodomain inhibitors
-
55. Ultra-large library docking for discovering new chemotypes
-
56. Evolution of commercially available compounds for HTS
-
57. (Chlorosulfonyl)benzenesulfonyl Fluorides—Versatile Building Blocks for Combinatorial Chemistry: Design, Synthesis and Evaluation of a Covalent Inhibitor Library
-
58. Facile One-Pot Parallel Synthesis of 3-Amino-1,2,4-triazoles
-
59. Saturated Heterocyclic Aminosulfonyl Fluorides: New Scaffolds for Protecting-Group-Free Synthesis of Sulfonamides
-
1. An algorithmic framework for synthetic cost-aware decision making in molecular design
-
2. Enhanced Calculation of Property Distributions in Chemical Fragment Spaces
-
3. Navigating large chemical spaces in early-phase drug discovery
-
4. Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses
-
5. Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration
-
6. Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining
-
7. Degradation Characteristics of a Novel PAF Receptor Antagonist, SY0916, in Aqueous Solution
